Provided by Tiger Trade Technology Pte. Ltd.

Fulcrum Therapeutics

3.82
-0.0100-0.26%
Volume:455.22K
Turnover:1.74M
Market Cap:291.46M
PE:-3.16
High:3.86
Open:3.84
Low:3.78
Close:3.83
52wk High:15.74
52wk Low:2.83
Shares:76.30M
Float Shares:63.49M
Volume Ratio:0.21
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2104
EPS(LYR):-1.1819
ROE:-32.38%
ROA:-19.59%
PB:0.94
PE(LYR):-3.23

Loading ...

Jun 05, 2026

Major Issues Report

Form 8-K - Current report
Jun 02, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 27, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2026

Major Issues Report

Form 8-K - Current report
Feb 24, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Dec 10, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 29, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Aug 28, 2025

Major Issues Report

Form 8-K - Current report
Jul 29, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]